Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | CHUK | O15111 | 1/20 | 0.45 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18428553 | 1.00 | CYP1A2 (0.52) | CYP1A2CYP2C9CYP2C19TLR8TSHR | |
| SCHEMBL30861903 | 1.00 | CYP1A2 (0.52) | CYP1A2CYP2C9CYP2C19TLR8TSHR | |
| SCHEMBL2252027 | 1.00 | CYP1A2 (0.52) | CYP1A2CYP2C9CYP2C19TLR8TSHR | |
| SCHEMBL10595283 | 1.00 | CYP1A2 (0.52) | CYP1A2CYP2C9CYP2C19TLR8TSHR | |
| SCHEMBL7044142 | 0.98 | CYP1A2 (0.53) | CYP1A2CYP2C9CYP2C19TLR8TSHR | |
| SCHEMBL11579460 | 0.91 | CYP1A2 (0.52) | CYP1A2CYP2C9CYP2C19TLR8TSHR | |
| SCHEMBL19980862 | 0.88 | MEN1 (0.55) | CYP1A2CYP2C9CYP2C19TLR8TSHR | |
| SCHEMBL15826627 | 0.87 | CYP1A2 (0.44) | CYP1A2CYP2C9CYP2C19TLR8TSHR | |
| SCHEMBL11225207 | 0.85 | SMPD1 (0.47) | CYP1A2CYP2C9CYP2C19TLR8TSHR | |
| SCHEMBL2367661 | 0.85 | TLR8 (0.54) | CYP1A2CYP2C9CYP2C19TLR8TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2260035-B1 | POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX KK (JP) | 2014-08-20 | — | — | EP | disclosed |
| EP-2260035-B1 | POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX KK (JP) | 2014-08-20 | — | — | EP | disclosed |
| US-20110149393-A1 | Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof | Crysoptic KK (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110149393-A1 | Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof | Crysoptic KK (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110149393-A1 | Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof | Crysoptic KK (JP) | 2011-06-23 | — | — | US | disclosed |
| EP-2260035-A2 | POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX K.K. (JP) | 2010-12-15 | — | — | EP | disclosed |
| WO-2009109781-A2 | POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX K.K. (JP) | 2009-09-11 | — | — | WO | disclosed |
| WO-2009109781-A2 | POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX K.K. (JP) | 2009-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110149393-A1 | Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof | CCNB1, CCNB2, CCNE2 | CYP1A2 213/4885CYP2C9 242/4885CYP2C19 414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.